ArticleGeneral thoracic and cardiovascular surgery2026
Prognostic significance of postoperative serum C-reactive protein levels after minimally invasive esophagectomy for esophageal cancer.
Article in General thoracic and cardiovascular surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePostoperative inflammation can promote immunosuppression and cancer recurrence. The present study investigated the correlation between serum C-reactive protein (CRP) levels after minimally invasive esophagectomy and long-term patient outcomes with large scale of cases.
methodsData from 329 patients who underwent minimally invasive esophagectomy were analyzed. Serum CRP levels were measured from postoperative day (POD) 1 to 7, 10, and 14. Low and high CRP groups were stratified by the median CRP values for each POD. Overall survival (OS) was defined as the time from esophagectomy to patient death. Relapse-free survival (RFS) was defined as the time to disease relapse or death from other cause.
resultsThe high CRP group on PODs 5-7 and 10 had a significantly lower OS rate than the low CRP group. The high CRP group on POD 6, 7, and 10 also had a significantly lower RFS rate than the low CRP group. A high CRP level on POD 7 was identified as an independent risk factor for poor OS/RFS. In contrast, preoperative CRP levels (before esophagectomy) were not identified as a risk factor for unfavorable OS/RFS. The high CRP group had a higher mortality rate from other diseases than the low CRP group (15.0% vs 8.9%). Secondary malignancies tended to be more frequent in the high CRP group than in the low CRP group (26.1% vs 6.3%).
conclusionElevated CRP levels in the immediate postoperative period after minimally invasive esophagectomy, particularly on POD 7, were significantly associated with poor OS and RFS.
Indexed as
Identifiers
41085948What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.